DE GREGORIO, DANILO
 Distribuzione geografica
Continente #
NA - Nord America 246
EU - Europa 185
AS - Asia 11
SA - Sud America 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 447
Nazione #
US - Stati Uniti d'America 242
SE - Svezia 121
IT - Italia 39
DE - Germania 8
CA - Canada 4
CN - Cina 4
FI - Finlandia 4
ES - Italia 3
IE - Irlanda 3
IL - Israele 3
CO - Colombia 2
GB - Regno Unito 2
HU - Ungheria 2
IN - India 2
UA - Ucraina 2
AU - Australia 1
BW - Botswana 1
EU - Europa 1
IR - Iran 1
NL - Olanda 1
SG - Singapore 1
Totale 447
Città #
Ashburn 66
Lawrence 31
Princeton 30
Seattle 13
New York 10
Milan 6
Urbino 5
Helsinki 4
Shanghai 4
Dublin 3
Los Angeles 3
Montorso Vicentino 3
Toronto 3
Turin 3
Alessandria 2
Barranquilla 2
Boardman 2
Budapest 2
Costa Mesa 2
Forlì 2
Genoa 2
Laurel 2
Leipzig 2
London 2
Rishon LeTsiyyon 2
Susegana 2
Trento 2
Washington 2
Bridgeton 1
Catanzaro 1
Chions 1
Corona 1
Fremont 1
Gaborone 1
Leawood 1
Naaldwijk 1
Nuremberg 1
Orleans 1
Palermo 1
Philadelphia 1
Pune 1
Rockville 1
Rome 1
Santa Clara 1
Singapore 1
Somerville 1
Sydney 1
Tel Aviv 1
Zanjan 1
Totale 233
Nome #
D-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders 31
D-Lysergic Acid Diethylamide (LSD) as a model of psychosis: Mechanism of action and pharmacology 27
Role of palmitoylethanolamide (PEA) in depression: Translational evidence: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders. 19
Dysfunction of serotonergic activity and emotional responses across the light-dark cycle in mice lacking melatonin MT2 receptors 19
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain 18
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline 18
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder 18
A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs 16
Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry 16
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome 15
The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors 15
Melatonin MT1 and MT2 receptors exhibit distinct effects in the modulation of body temperature across the light/dark cycle 15
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice 15
Dorsal striatum metabotropic glutamate receptor 8 affects nocifensive responses and rostral ventromedial medulla cell activity in neuropathic pain conditions 15
Behavioral, biochemical and electrophysiological changes in spared nerve injury model of neuropathic pain 14
Antidepressant actions of ketamine engage cell-specific translation via eIF4E 14
A Key Role for Prefrontocortical Small Conductance Calcium-Activated Potassium Channels in Stress Adaptation and Rapid Antidepressant Response 14
Effects of Chronic Exposure to Low-Dose delta-9-Tetrahydrocannabinol in Adolescence and Adulthood on Serotonin/Norepinephrine Neurotransmission and Emotional Behavior 13
Acanthoscurria gomesiana spider-derived Mygalin in the prelimbic prefrontal cortex modulates neuropathic pain and depression comorbid 12
Editorial: Methods and applications in addiction psychiatry research: 2021 12
Targeting melatonin MT2 receptors: A novel pharmacological avenue for inflammatory and neuropathic pain 12
Melatonin MT 1 receptor as a novel target in neuropsychopharmacology: MT 1 ligands, pathophysiological and therapeutic implications, and perspectives 12
Effects of metabolites of the analgesic agent dipyrone (metamizol) on rostral ventromedial medulla cell activity in mice 12
Characterization of the sensory, affective, cognitive, biochemical, and neuronal alterations in a modified chronic constriction injury model of neuropathic pain in mice 12
Acute and Chronic Pain Preclinical Models to Study the Analgesic Properties of Melatonergic Compounds 11
Supraspinal melatonin MT2 receptor agonism alleviates pain via a neural circuit that recruits mu opioid receptors 11
Hypnotic Effects of Melatonergic Compounds Measured in Mice or Rats 11
Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1R signaling and anxiety-like behavior 11
Ketones and pain: Unexplored role of hydroxyl carboxylic acid receptor type 2 in the pathophysiology of neuropathic pain 11
Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E 9
Hallucinogens in mental health: Preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine 9
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms 9
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice 8
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission 8
Nociceptive responses in melatonin MT2 receptor knockout mice compared to MT1 and double MT1/MT2 receptor knockout mice 7
MMPIP, an mGluR7-selective negative allosteric modulator, alleviates pain and normalizes affective and cognitive behavior in neuropathic mice 7
Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling 6
Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice 6
null 1
Totale 509
Categoria #
all - tutte 6.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.071


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 3 0 0 0 0 0 0 0 0 0 0 2
2021/202253 0 0 0 6 3 0 0 19 1 1 18 5
2022/2023258 75 56 21 1 6 23 5 26 10 1 29 5
2023/2024184 7 14 24 60 25 29 2 16 3 4 0 0
Totale 509